Rosa Alves
Assistant Dean for Global Compliance & Programming, Seton Hall Law School (New Jersey,
United States)
[email protected] | 973-642-8382
PROGRAM SCHEDULED for February 3-6, 2025 | In-Person | Dubai, UAE
8:30 am
REGISTRATION
9:00 - 9:45am
Welcome, Format Review, Introductions & Ice Breaker
Rosa Alves
Assistant Dean for Global Compliance & Programming, Seton Hall Law School (New Jersey,
United States)
Kathleen M. Boozang
Dean & Professor of Law, Seton Hall Law School (New Jersey, United States)
9:50 - 10:40
Aligning the “Why” and “How” of Compliance:
- What is Corruption?
- What is a Conflict of Interest?
- Business Ethics
- How is Compliance Best Achieved?
- Values vs. Rules1
Kathleen M. Boozang
Dean & Professor of Law, Seton Hall Law School (New Jersey, United States)
10:40 - 10:55
Break
10:55 - 12:10
Global Anti-Corruption Enforcement:
- Global Anti-Corruption Treaties and Standards (OECD, UNCAC, ISO37001)
- Overview of US Foreign Corrupt Practices Act (FCPA) and UK Bribery Act
Yuet Ming Tham
Partner, Global Co-Leader, White Collar: Government Litigation & Investigations Practice,
Sidley Austin LLP
12:10 - 13-10
Lunch Break
13:10 - 14:25
Being the Focus of a Government Investigation:
- Risk to and Rights of Employees
- The Issue of Legal Privilege
- How to Respond to Inquiries
- Business Continuity Plans
Giuseppe “Pino” Falbo
Global Head, Ethics & Compliance Investigations, Takeda (Dubai)
Orlando Vidal
Partner, Norton Rose Fulbright (Middle East) LLP (Dubai)
14:30 - 15:30
Middle East Anti-Corruption Laws
Nicholas Cameron
Partner, Head of Forensic, KPMG Lower Gulf (Dubai)
Alexander Tuscano
Director, Forensic, KPMG Lower Gulf Limited (United Arab Emirates)
15:30 - 15:45
Break
15:50 - 16:40
Common Pitfalls in an Ethics and Compliance Program
Robin Singh
Compliance & Ethics Lead, Healthcare Government Entity (Abu Dhabi)
8:30
9:00 - 10:15
Global and Regional Industry Codes (Pharma & Device)
Rami Hamarneh
Senior Compliance Lead, Middle East, Africa & CEETRIS Region, Roche Pharmaceuticals
(Dubai, United Arab Emirates)
Laura Nassar
Vice President, Head of Ethics and Business Integrity, AEME Region, Sanofi (Dubai)
10:15 - 10:30
Break
10:30 - 12:30
Strategy to Maintaining Standards, Patient Confidence, and Control in the Midst of an On-Going or Anticipated Dispute & Trade Sanctions & Expert Controls
Ghalib Mahmoud
Senior Associate, Hadef & Partners (Dubai)
12:30 - 14:00
Lunch Break
14:00 - 15:15
Emerging Risk Area: Patient Support Programs
Ghada El Ehwany
Partner, Baker McKenzie, Helmy, Hamza and Partners (Cairo)
Els Janssens
Counsel, Baker McKenzie (Brussels)
Rim El Kassaby
Director, US Director Global Counseling & Support, Organon & Co. (New Jersey, United
States)
15:15 - 15:30
Break
15:30 - 17:00
Compliance Officers Panel Discussion
- CO leadership traits
- CO responsibilities regarding global guidelines & policies
- Audience Q&A
Giuseppe “Pino” Falbo
Global Head, Ethics & Compliance Investigations, Takeda (Dubai)
Karina Griese-Brake
Head of Compliance Middle East, Turkey & Africa, Fresenius Medical Care Middle East
(Dubai)
Laura Nassar
Vice President, Head of Ethics and Business Integrity, AEME Region, Sanofi (Dubai)
Moderator: Kathleen M. Boozang
Dean & Professor of Law, Seton Hall Law School (New Jersey, United States)
17:00 - 18:00
Networking Reception
8:30
Registration
9:00 - 10:10
Assessing Third Party Risk:
- Key Risk Areas
- Due Diligence Best Practices
- Lessons Learned
Rim El Kassaby
Director, US Director Global Counseling & Support, Organon & Co. (New Jersey, United
States)
10:10 - 10:25
Break
10:25 - 12:00
Distributor Management Strategies in the Middle East
Lina S. Al-Abbadi
Regulatory Affairs & Quality Assurance Manager, Responsible Pharmacist, Petra Drug
Store (Jordan)
Karina Griese-Brake
Head of Compliance Middle East, Turkey & Africa, Fresenius Medical Care Middle East
(Dubai)
Moderator: Joe Henein
President & CEO, NewBridge Pharmaceuticals (Dubai)
12:00 - 13:10
Lunch Break
13:10 - 14:00
Healthcare in India: Regulatory Compliance (Prevention is Better Than a Cure)
Darren Punnen
Leader, Pharmaceutical & Life Sciences Practice, Nishith Desai Associates (Mumbai)
14:05 - 15:05
Data-Driven Analysis for Compliance Programs
Ghazanfar "Ghaz" Shah
Senior Managing Director, Investigations and Disputes Practice, K2 Integrity (UAE)
15:05 - 15:20
Break
15:20 - 16:30
Anti-Corruption Settlements
- What Went Wrong: Operationalizing Lessons Learned from Recent Enforcement Actions
John Kelly
Partner & Chair of the Healthcare Department and Industry Practice, Barnes & Thornburg LLP (Washington, D.C., USA)
Fabiana Lacerca-Allen
Senior Vice President, Compliance, Aimmune Therapeutics (California, United States)
Prashant Oza
Area Director - Office of Ethics and Compliance, Allergan Aesthetics, An AbbVie Company
(Dubai, UAE)
16:35 - 17:00
A Journey to the Dark Side of International Business: Real-World Risk and Real-World Lessons—Ask Richard
Richard Bistrong
CEO, Front-Line Anti-Bribery LLC (Connecticut, United States)
8:30
Registration
9:00 - 9:50
Country-Specific Session: Anti-Corruption Rules Turkey
Dicle Doğan
Managing Associate, Gün + Partners (Istanbul)
9:55 - 10:45
The Importance of Culture and Ethics in Building and Growing a Compliance Team
Roeland Van Aelst
EMEA Lead Third Party Intermediary Ethics & Compliance, Johnson & Johnson (Antwerp)
10:45 - 11:00
Break
11:00 - 13:00
Interactive Session
Case Study – Part 1
Prep Session
13:00 - 14:00
Lunch Break
14:00 - 15:30
Interactive Session
Case Study – Part 2
Team Presentations & Classroom Discussion
Laura Nassar
Vice President, Head of Ethics and Business Integrity, AEME Region, Sanofi (Dubai)
15:30
Closing Remarks
Rosa Alves
Assistant Dean for Global Compliance & Programming, Seton Hall Law School (New Jersey,
United States)
